Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ticker | Board | News | Price | Change | Chg% | Added | ||||
---|---|---|---|---|---|---|---|---|---|---|
Sandstorm Metals and Energy Ltd (fka STTYF) | 07/27/2013 | |||||||||
SAND | Sandstorm Gold Ltd | 6.04 | 0.03 | 0.50% | 07/27/2013 | |||||
Lpath Inc fka LPTN | 06/28/2013 | |||||||||
NGT | Newmont Goldcorp Corp | 60.14 | 0.54 | 0.91% | 06/28/2013 | |||||
RGLD | Royal Gold | 133.98 | -0.29 | -0.22% | 06/28/2013 | |||||
ABX | Barrick Gold Corp | 24.3 | -0.03 | -0.12% | 06/28/2013 | |||||
CTSO | CytoSorbents Corporation | 0.922 | -0.0574 | -5.86% | 08/13/2012 | |||||
My CTSO Pitch: The principle medical device of CTSO is Cytosorb, a bead filter, that effectively removes Cytokines through dialysis. Cytosorb has been shown to reduce multiple organ failure and death in severe sepsis through cytokine reduction.
“An investigational device exemption (IDE) to initiate clinical |
||||||||||
AEMD | Aethlon Medical Inc | 0.4299 | -0.0019 | -0.44% | 08/09/2012 | |||||
My AEMD Pitch: The AEMD Hemopurifier has been shown in initial very small studies to remove HCV viruses effectively in combination with anti-viral agents. It has been approved for compassionate usage. GILD and other companies interested in agents for HCV will not overlook the AEMD technology.
|